FR2810047B1 - Nouvelle isoforme d'hla-g et ses applications - Google Patents

Nouvelle isoforme d'hla-g et ses applications

Info

Publication number
FR2810047B1
FR2810047B1 FR0007529A FR0007529A FR2810047B1 FR 2810047 B1 FR2810047 B1 FR 2810047B1 FR 0007529 A FR0007529 A FR 0007529A FR 0007529 A FR0007529 A FR 0007529A FR 2810047 B1 FR2810047 B1 FR 2810047B1
Authority
FR
France
Prior art keywords
hla
applications
new isoform
isoform
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0007529A
Other languages
English (en)
Other versions
FR2810047A1 (fr
Inventor
Edgardo Delfino Carosella
Pascale Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to FR0007529A priority Critical patent/FR2810047B1/fr
Priority to PCT/FR2001/001827 priority patent/WO2001096564A2/fr
Publication of FR2810047A1 publication Critical patent/FR2810047A1/fr
Application granted granted Critical
Publication of FR2810047B1 publication Critical patent/FR2810047B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0007529A 2000-06-13 2000-06-13 Nouvelle isoforme d'hla-g et ses applications Expired - Fee Related FR2810047B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0007529A FR2810047B1 (fr) 2000-06-13 2000-06-13 Nouvelle isoforme d'hla-g et ses applications
PCT/FR2001/001827 WO2001096564A2 (fr) 2000-06-13 2001-06-13 Isoforme d'hla-g (hla-g7) et ses applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007529A FR2810047B1 (fr) 2000-06-13 2000-06-13 Nouvelle isoforme d'hla-g et ses applications

Publications (2)

Publication Number Publication Date
FR2810047A1 FR2810047A1 (fr) 2001-12-14
FR2810047B1 true FR2810047B1 (fr) 2004-04-02

Family

ID=8851220

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007529A Expired - Fee Related FR2810047B1 (fr) 2000-06-13 2000-06-13 Nouvelle isoforme d'hla-g et ses applications

Country Status (2)

Country Link
FR (1) FR2810047B1 (fr)
WO (1) WO2001096564A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287556A1 (en) * 2004-05-06 2005-12-29 Carole Ober Use of HLA-G genotyping in immune-mediated conditions
WO2007011044A1 (fr) * 2005-07-15 2007-01-25 Kyushu University, National University Corporation Composition pharmaceutique comprenant un dimere hla-g lie disulfide et procede de fabrication de ce dimere hla-g lie disulfide
FR2934498B1 (fr) * 2008-08-01 2014-08-15 Commissariat Energie Atomique Utilisation d'une forme soluble d'hla-g dans le traitement des proliferations anormales des lymphocytes b.
EP2184070A1 (fr) 2008-11-07 2010-05-12 Hla-G Technologies Protéines HLA-G et leurs utilisations pharmaceutiques
EP2443147A1 (fr) * 2009-06-18 2012-04-25 Hla-G Technologies Multimères alpha 1 de hla-g et leurs utilisations pharmaceutiques
EP2264067A1 (fr) 2009-06-18 2010-12-22 Hla-G Technologies Multimères de HLA-G alpha 1 et leurs utilisations pharmaceutiques
EP2445934B1 (fr) 2009-06-25 2014-07-16 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Polypeptides multimères de hla-g comprenant au moins deux domaines alpha3 et leurs utilisations pharmaceutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031604A1 (fr) * 1995-04-07 1996-10-10 The Regents Of The University Of California Anticorps pour la detection de hla-g
FR2760023B1 (fr) * 1997-02-21 2004-05-07 Commissariat Energie Atomique Cellules eucaryotes exprimant a leur surface au moins une isoforme d'hla-g et leurs applications
EP1054688B1 (fr) * 1998-02-20 2004-06-30 Commissariat A L'energie Atomique Methode de selection de tumeurs exprimant hla-g, sensibles a un traitement anticancereux et ses applications
AU2636399A (en) * 1998-02-25 1999-09-15 National University Of Ireland, Cork Hla linked pre-eclampsia and miscarriage susceptibility gene
FR2794977B1 (fr) * 1999-06-18 2003-10-31 Commissariat Energie Atomique Utilisation de compositions contenant des formes solubles d'hla-g dans le traitement de pathologies inflammatoires de la peau, et leur procede d'obtention

Also Published As

Publication number Publication date
WO2001096564A3 (fr) 2002-03-14
FR2810047A1 (fr) 2001-12-14
WO2001096564A2 (fr) 2001-12-20

Similar Documents

Publication Publication Date Title
FR2807810B1 (fr) Structure d'amortissement et applications
FR12C0012I2 (fr) Combinaisons d'herbicides et de phytoprotecteurs
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
AU2001240042A1 (en) Methods and devices to expand applications of intraoperativeradiation probes
DZ3251A1 (fr) Nouvelle composition et son utilisation
FR2819410B1 (fr) Composition cosmetique irisee et ses utilisations
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
PT1263745E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao para a inibicao da lipase sensivel a hormonas
DE60023389D1 (de) Farblose Polymaleate und ihre Anwendungen
DE69819193D1 (de) Dehnungsmessstreifen und dessen anwendungen
DE60121951D1 (de) Charakterisierung nichtlinearen Verhaltens
FR2810047B1 (fr) Nouvelle isoforme d'hla-g et ses applications
FR2819411B1 (fr) Composition cosmetique irisee et ses utilisations
FR2810154B1 (fr) Module de condensateur d'onduleur et onduleur
FR2839237B1 (fr) Structures et proprietes d'elements transducteurs d'harmoniques
FR2819412B1 (fr) Composition cosmetique irisee et ses utilisations
ITMI20021103A0 (it) Soffietto con un'estremita' libera
EE200300483A (et) Uudsed ekspressioonivektorid ja nende rakendused
FR2772268B1 (fr) Nouvelle composition cosmetique autobronzante et antideshydratante
ID25910A (id) Gen-gen biosintesis riboflavin dari tanaman dan penggunaan-penggunaannya
FR2823975B1 (fr) Nouvelle utilisation de pyridoindolone
NO20031537L (no) Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin
FR2825714B1 (fr) Nouvelle utilisation de complexes d'inclusion de cyclodestrine
DE60039319D1 (de) Asphärische Ojektivlinse und Herstellungsverfahren derselben
IT1313379B1 (it) Trasconduttore mos con ampio campo di tarabilita'

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140228